| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/04/2007 | WO2005012491A3 Surface expression of biologically active proteins in bacteria |
| 01/04/2007 | US20070006333 Selecting animals for desired genotypic or potential phenotypic properties |
| 01/04/2007 | US20070004668 Antisense permeation enhancers |
| 01/04/2007 | US20070004667 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004666 Methods for modulating apoptotic cell death |
| 01/04/2007 | US20070004665 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004664 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004663 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004662 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
| 01/04/2007 | US20070004661 Antisense antiviral compound and method for treating influenza viral infection |
| 01/04/2007 | US20070004660 Synergistic Modulation of Flt3 Kinase Using Alkylquinolines and Alkylquinazolines |
| 01/04/2007 | US20070004659 Method for preventing or delaying the onset of diabetes |
| 01/04/2007 | US20070004658 Method and means for treatment of osteoarthritis |
| 01/04/2007 | US20070004657 Diagnosis and treatment of kidney fibrosis and other fibrotic diseases |
| 01/04/2007 | US20070004656 transfer the sialic acids from a donor molecule (eg. oligosaccharides) to acceptor molecule (eg. oligo- and polysaccharides); foodstuffs or food additives |
| 01/04/2007 | US20070004655 Nr-cam gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors |
| 01/04/2007 | US20070004632 An isolated BAX gene frameshift-mutation polypeptide is used to stimulate the proliferation of human T cells, T cellular immunity; for treating cancer patient; cancer vaccines |
| 01/04/2007 | US20070004628 Compositions and methods for nerve regeneration |
| 01/04/2007 | US20070004624 Methods for modulating bone tissue formation, orthogenic agents and pharmaceutical compositions |
| 01/04/2007 | US20070004621 Bex4 nucleic acids, polypeptides, and method of using |
| 01/04/2007 | US20070004008 Human ccv polypeptides |
| 01/04/2007 | US20070004002 Stably, extrachromosomally held in mammalian host cells, allows efficient expression of a target gene; first cyclic vector contains centromere sequence, selection marker gene; second vector contains functional sequence transferred into mammalian host cells |
| 01/04/2007 | US20070003970 PAK 2: modulators of lymphocyte activation |
| 01/04/2007 | US20070003963 RNA sequence-specific mediators of RNA interference |
| 01/04/2007 | US20070003962 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003961 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003960 Producing knockdown cells; Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response |
| 01/04/2007 | US20070003610 Application of lipid vehicles and use for drug delivery |
| 01/04/2007 | US20070003609 Vectorization of dsRNA by cationic particles and topical use |
| 01/04/2007 | US20070003589 Coatings for implantable medical devices containing attractants for endothelial cells |
| 01/04/2007 | US20070003577 Purified trimeric S protein as vaccine against severe acute respiratory syndrome virus infections |
| 01/04/2007 | US20070003571 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 01/04/2007 | US20070003563 Multivalent entrain-and-amplify immunotherapeutics for carcinoma |
| 01/04/2007 | US20070003558 with inhibitors of chemokine receptor (CXCR4); gene expression inhibition; decreases homing of cells to bone marrow and reduces disease development; administered via osmotic pump |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/04/2007 | US20070003533 Inhibition of the beta3 subunit of L-type Ca2+ channels |
| 01/04/2007 | US20070003532 Novel mechanism for identifying drugs for the treatment of type II diabetes |
| 01/04/2007 | US20070003531 Methods for improving immunotherapy by enhancing survival of antigen-specific cytotoxic T lymphocytes |
| 01/04/2007 | US20070003530 Cardiac muscle regeneration using mesenchymal stem cells |
| 01/04/2007 | US20070003529 Generating teeth from bone marrow cells |
| 01/04/2007 | US20070003524 Targeted retrograde gene delivery to motor neurons |
| 01/04/2007 | US20070003523 Short interference ribonuclic acids for treatment and prevention of diabetic retinopathy, age related macular degeneration and cancer; gene expression inhibition |
| 01/04/2007 | US20070003522 Methods and compositions for improved retroviral gene and drug delivery |
| 01/04/2007 | US20070003521 Expression vectors containing hybrid ubiquitin promoters |
| 01/04/2007 | US20070003520 Mutant viruses |
| 01/04/2007 | US20070003519 reducing ICT1024 expression; inhibitor is an siRNA, shRNA, antisense RNA, antisense DNA, decoy molecule, decoy DNA, double stranded DNA, single-stranded DNA, complexed DNA, encapsulated DNA, viral DNA, plasmid DNA, naked RNA, encapsulated RNA, viral RNA, double stranded RNA, RNA interference; cancer |
| 01/04/2007 | US20070003518 Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases |
| 01/04/2007 | US20070003517 administering to a target tissue a nucleic acid that encodes a polypeptide inhibiting c-Jun NH2-terminal kinase (JNK) activity in a target tissue; Parkinson's and Alzheimer's disease; arthritis |
| 01/04/2007 | CA2617222A1 Peptide derived from prostate-related protein as cancer vaccine candidate for prostate cancer patient who is positive for hla-a3 super-type allele molecule |
| 01/04/2007 | CA2613551A1 Neuroprotective effective compound |
| 01/04/2007 | CA2613310A1 Use of mutant herpes simplex virus-2 for cancer therapy |
| 01/04/2007 | CA2613284A1 Methods and compositions for expressing negative-sense viral rna in canine cells |
| 01/04/2007 | CA2613166A1 Modulation of negative immune regulators and applications for immunotherapy |
| 01/04/2007 | CA2609142A1 Therapeutic gene vectors comprising mirna target sequences |
| 01/04/2007 | CA2608964A1 Rnai modulation of hif-1 and therapeutic uses thereof |
| 01/04/2007 | CA2584803A1 Disimmortalizable mammalian chromaffin cell lines for cell therapy for pain |
| 01/03/2007 | EP1739186A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 01/03/2007 | EP1739178A2 Delivery of trefoil peptides |
| 01/03/2007 | EP1739176A1 Decoy nucleic acid to synoviolin gene promoter |
| 01/03/2007 | EP1739173A1 Kit for solid cancer diagnosis and medicine for solid cancer therapy |
| 01/03/2007 | EP1739171A1 Novel gene participating in epidermal differentiation and use thereof |
| 01/03/2007 | EP1738772A1 Micro rna inhibiting the expression of wt1 gene and utilization of the same |
| 01/03/2007 | EP1738771A1 siRNA CAPABLE OF INHIBITING EXPRESSION OF WT1 GENE AND USE THEREOF |
| 01/03/2007 | EP1737983A2 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 01/03/2007 | EP1737885A2 Method of using adenoviral vectors to induce an immune response |
| 01/03/2007 | EP1737498A2 Zinc finger proteins for treatment of neuropathic pain |
| 01/03/2007 | EP1737493A2 Inhibitors of insulin-like growth factor receptor -1 for inhibiting tumour cell growth |
| 01/03/2007 | EP1660099A4 Intravascular delivery of non-viral nucleic acid |
| 01/03/2007 | EP1448771B1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof |
| 01/03/2007 | EP1436389B1 Thrombin-cleavable chimeric proteins |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1304371B1 Cds1 knockout mice and cell lines established thereof |
| 01/03/2007 | EP1278534B1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/03/2007 | EP1154756B1 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 01/03/2007 | EP1104462B1 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 01/03/2007 | EP1082463B1 Mechanical stress induced genes, expression products therefrom, and uses thereof |
| 01/03/2007 | EP0904090B1 Egg anti-inflammatory composition, method of isolation and use |
| 01/03/2007 | EP0776361B1 Recombinant herpesvirus of turkeys and uses thereof |
| 01/03/2007 | EP0526452B2 Hybrid immunoglobulins |
| 01/03/2007 | CN1890383A Hinge core mimetibodies, compositions, methods and uses |
| 01/03/2007 | CN1890375A 核酸构建体 Nucleic acid construct |
| 01/03/2007 | CN1890261A Protein NMB0928 and use thereof in pharmaceutical formulations |
| 01/03/2007 | CN1890260A Protein NMB1125 and use thereof in pharmaceutical formulations |
| 01/03/2007 | CN1889963A 方法 Method |
| 01/03/2007 | CN1887896A Tumor inhibiting antisense nucleotide |
| 01/03/2007 | CN1887343A Application of cell factor in resisting tuberculosis infection |
| 01/03/2007 | CN1887273A Prepn process of polysaccharide vitreous particle |
| 01/03/2007 | CN1293196C Novel recombinant adenovirus vector with relieved side effects |
| 01/03/2007 | CN1293081C 28-epirapalogs, preparation method, medicament composition and use |
| 01/03/2007 | CN1292797C Immune regulator, immune regulator food and immune regulator fodder |
| 01/02/2007 | US7157570 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders |
| 01/02/2007 | US7157569 Comprises nucleotide sequences coding gamma aminobutyric acid type A (GABAA) receptor for diagnosis and treatment of brain, anxiety, depressive, nervous system, migraine and/or obesity disorders |
| 01/02/2007 | US7157439 a cellulose and a HoxB3 homeotic nucleic acid or protein; improved neovascularization |
| 01/02/2007 | US7157437 Administering polynucleotide comprising an immunostimulatory sequence (ISS) to an individual exposed to herpes simplex virus, wherein the ISS comprises the sequence 5'-C, G-3', wherein the polynucleotide comprises a phosphate backbone modification, wherein the polynucleotide is greater than 6 nucleotides |
| 01/02/2007 | US7157436 An specific oligonucleotide sequence conataining 2-20 base 3'OH, 5'OH synthetic oligonucleotide which induces a response selected from cell cycle arrest, inhibition of cell proliferation, activation of caspases in cancer cells |
| 01/02/2007 | US7157435 Delivering a dosage of a growth factor-encoding transgene composition to preselected delivery sites in the brain where the encoded growth factor is expressed and stimulates axonal growth; mimimally invasive; Alzheimer's, Parkinson diseases |
| 01/02/2007 | US7157425 Apolipoprotein agonist for use in the treatment of dyslipidemia |
| 01/02/2007 | US7157266 Structure of adenovirus bound to cellular receptor car |
| 01/02/2007 | US7157259 Murine lecithin-cholesterol acyltransferase protein |
| 01/02/2007 | US7157248 Anticonvulsants; anxiolytic agents; multiple sclerosis; isolated nucleic acids; analyzing sample; calibration |